These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4819884)

  • 1. Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients.
    Cummings YE; Dillard MG
    J Natl Med Assoc; 1974 Mar; 66(2):104-7 passim. PubMed ID: 4819884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant arterial hypertension. Intensive treatment by acute sodium depletion and antihypertensive agents].
    Baglin A; Safar M; Milliez P
    Nouv Presse Med; 1972 Jan; 1(5):299-304. PubMed ID: 5010444
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of malignant arterial hypertension by acute dehydration with sodium depletion and antihypertensive drugs.
    Baglin A; Safar M; Milliez P
    Mater Med Pol; 1972; 4(3):121-9. PubMed ID: 4664414
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hypertension].
    van Ypersele de Strihou C; Loute G
    Rev Med Suisse Romande; 1974 Nov; 94(11):903-7. PubMed ID: 4155113
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant hypertension; practical and theoretical lecture on account of one patient].
    Wijdeveld PG; Tiggeler RG
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):2-9. PubMed ID: 5028744
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible acute renal faiure in diffuse scleroderma.
    Ponticelli C; Ambroso G; Graziani G; Rossi E
    Clin Nephrol; 1980 Jun; 13(6):293-5. PubMed ID: 7408249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
    Markenson JA; Sherman RL
    Arthritis Rheum; 1979 Oct; 22(10):1132-4. PubMed ID: 158363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medical treatment of severe or malignant arterial hypertension].
    Safar M; Milliez P
    Rev Prat; 1972 May; 22(15):2433-45. PubMed ID: 4646998
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kidney involvement in scleroderma].
    Ritz E
    Dtsch Med Wochenschr; 1981 Jan; 106(1):23-5. PubMed ID: 7449652
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with hemodialysis and renal transplantation in patients with malignant hypertension.
    Acchiardo SR; Black WD; Britt L; McKeown JW; Johnson JG; Hatch F
    Proc Clin Dial Transplant Forum; 1974; (4):70-3. PubMed ID: 4619667
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical management of renal scleroderma.
    Cannon PJ
    N Engl J Med; 1978 Oct; 299(16):886-7. PubMed ID: 357974
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypertension in the malignant phase: some current aspects of physiopathology and therapy].
    Amato M; Bertoni E; Forti G; Salvadori M; Sodi A; Constantini A
    Recenti Prog Med; 1977 Jul; 63(1):13-20. PubMed ID: 578580
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant hypertension. Current modes of therapy.
    Dranov J; Skyler JS; Gunnells JC
    Arch Intern Med; 1974 May; 133(5):791-801. PubMed ID: 4595400
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant hypertension (clinico-pathological study of 88 patients).
    Almeida AF; Bhivandkar MG; Khanna UB; Shah BV; Karnad D; Mittal BV; Kinare SG; Acharya VN
    J Assoc Physicians India; 1986 Aug; 34(8):563-6. PubMed ID: 3793675
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant hypertension in children in India.
    Kumar P; Arora P; Kher V; Rai PK; Gulati S; Baijal SS; Kumar S
    Nephrol Dial Transplant; 1996 Jul; 11(7):1261-6. PubMed ID: 8672020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and treatment of malignant hypertension.
    Pérez-Grovas H; Herrera-Acosta J
    Semin Nephrol; 1988 Jun; 8(2):147-54. PubMed ID: 3293138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of certain factors in prognosis of the course of malignant hypertension in terminal stage of chronic renal insufficiency and the problems of therapeutic tactics].
    Shraer TI; Torgunakov AP; Gorbunov VV; Osipov LE
    Urol Nefrol (Mosk); 1976; (2):18-22. PubMed ID: 982716
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical picture and therapy of malignant hypertension].
    Schoeppe W; Brecht HM; Koch KM
    Med Welt; 1975 Mar; 26(10):417-21. PubMed ID: 1123984
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin therapy for the renal disease of malignant hypertension.
    Zimmerman SW; Bergin JJ
    Nephron; 1974; 12(3):219-30. PubMed ID: 4600972
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant hypertension: still a challenge.
    Beutler JJ; Koomans HA
    Nephrol Dial Transplant; 1997 Sep; 12(9):2019-23. PubMed ID: 9306367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.